Selective P2X4R agonist and antagonist ligands for theranostic modulation of neuroinflammation in Alzheimer's disease and multiple sclerosis
Drug discovery platform targeting the P2X4 receptor to modulate microglial neuroinflammation in Alzheimer's disease and multiple sclerosis. Combines medicinal chemistry, in vitro screening, in vivo validation in disease ...